September 2, 2014

FDA Wants $220M from Food Producers After Congress Already Said No

pin it button FDA Wants $220M from Food Producers After Congress Already Said No

fda logo FDA Wants $220M from Food Producers After Congress Already Said No

by Alliance for Natural Health

Can’t get what you want by legitimate means? Just try an end-run around the system!

The FDA has submitted its budget funding request for FY 2013. That request includes $220 million in food facility registration fees. FDA would use the money to “increase its capacity to establish an integrated national food safety system and further strengthen food safety inspection.”

What’s a food facility? Unfortunately, it may include a family farm or a Mom-and-Pop food stand. As it stands now, it’s anybody the FDA thinks is involved with food.

This facility registration user fee provision was in the original version of the Food Safety Modernization Act (FSMA). But that, after intense criticism from us and others, was struck from the final version that was signed into law in 2011. What this new budgetary request means is that FDA is trying to circumvent the law—and the clear intent of Congress, just as they did with the NDI guidance document.

Food fees can drive small producers out of business. That might make life easier for the FDA. Like other federal agencies, they may find it easier  to work with a small number of giant companies. But with or without the fees, food facility inspections can also be a big deal.

The original version of the Food Safety bill mandated that every registered facility must be inspected by the FDA. We and others were able to exempt small farms with less than $500,000 in sales from these new federal inspection requirements—so long as the majority of sales are direct to consumers, restaurants, or grocery stores and those restaurants and stores are in the same state or within 275 miles of the farm. However, many small and organic farms make just a little over $500,000 per year or do not meet all these specifications, so they are not  exempt.

Under the law, as passed, high-risk facilities will be inspected initially within the first five years and then every three years thereafter; low-risk facilities, initially within seven years, and then every five. The FDA would need to hire an additional 5,000 employees to do all the inspections. Big companies love this, because the FDA would be so bogged down inspecting all the smaller operations that they wouldn’t have time to focus on the big guys—where the actual food safety problems arise. Food safety legislation should be targeted at the large industrial farms, but, no surprise, the bill as passed did just the opposite.

Inspections are also an opportunity for FDA to go on fishing expeditions when they want to target a particular company or industry—they can be as finicky as they wish, citing harmless paperwork violations as huge offenses, for example.

While FDA has not said what specifically they would do with the $220 million in new registration fees they are trying to sneak into the federal budget, it is clear that they are trying to restore what was denied them by Congress in  the final version of the Food Safety bill.

The agency has also implemented interim rules for administrative detention—rules that give FDA wider authority to detain foods, including supplements. This means that if FDA even suspects that a violation has occurred, they can detain a food or supplement company’s full stock for up to twenty days (with a possible ten-day extension if FDA wishes to initiate legal action), which might be enough to destroy smaller companies.

Why does this matter? Just ask the cherry growers, who were almost driven out of business for citing peer-reviewed scientific research about the anti-inflammatory properties of cherries!

This can now happen even where FDA only thinks a violation has occurred. Let’s say FDA finds third-party praise for a supplement’s therapeutic properties on a website related or linked to from the supplement company. Even though it’s a gray area, FDA may decide to pull a company’s products and make them battle in the courts for a decision on whether a third-party testimonial is a health claim attributable to the company.

After a bill is passed into law, it usually goes through a rulemaking phase, where an agency will flesh out how all the specific provisions in the bill will be implemented. That’s where the FSMA is now—the process of writing all the rules for the Food Safety Act is still in process. FDA delivered four proposed rules to the White House’s Office of Management and Budget (OMB) toward the end of 2011, but the rules have been “stuck in review” at OMB since then.

The Consumer Federation of America (CFA), a coalition of 300 nonprofit consumer organizations, has urged FDA to make public the proposed rules dealing with preventative controls for food, animal feed, produce safety and food imports.

FDA has invited comment from the public on many of the topics covered by the FSMA, but the agency has yet to submit those four proposed rules for public comment. We will keep a close watch on the proposed rules, and as we promised to keep you updated on the process, will let you know as soon as they are released and open for comments.

One of the things mandated by the FSMA was guidance on New Dietary Ingredients. As you know, their guidance document was a disaster, and ANH-USA has asked them to withdraw the guidance altogether and start over—as have a number of senators and congressional representatives.

Regular readers will recall our serious concerns with the FSMA. And then there was the controversial way the bill was passed in the first place—the bill was dead until the Senate resurrected it as an amendment to a completely unrelated bill. You can see the full timeline of FSMA-related battles here.

Read the Full Story and Comment Here: http://www.anh-usa.org/fda-wants-220m-from-food-producers-after-congress-already-said-no/

0 commentsback to post

Other articlesgo to homepage

Study: Legalizing Medical Marijuana Leads to Fewer Prescription Drug Overdose Deaths

Study: Legalizing Medical Marijuana Leads to Fewer Prescription Drug Overdose Deaths

Pin It

A study published in the journal JAMA Internal Medicine on Monday found that states that had legalized medical marijuana had seen a 25 percent drop in deaths related to prescription drug overdoses.

According to ABC News, the researchers conducting the study found that because “legalizing medical marijuana makes it more available to chronic pain patients, it provides a potentially less lethal alternative to pain control on a long-term basis.”

Over the course of the study, the states studied were the ones that allowed access to medical marijuana. The Washington Post reported that those states “had 1,729 fewer overdose deaths in 2010 than would be predicted by trends in states without such laws.”

Dr. Marcus Bachhuber, a physician and researcher at the University of Pennsylvania, and the lead author of the study, told ABC News that while he did expect to see changes among the states that legalized medical marijuana, he found it “surprising that the difference is so big.”

Unapproved but Effective Cancer Cures

Unapproved but Effective Cancer Cures

Pin It

The conventional cancer treatment system and the pharmaceutical companies that control it are dedicated to limiting the development of all other forms of cancer treatment. They have a chokehold on the development of alternative treatments, and they ruthlessly work together with the US FDA and various US government cancer research funding agencies to prevent new treatments from being approved for use by physicians. The reason is that most alternative cancer treatments are much less expensive than surgery, radiation, and chemo. They are also more effective and have many fewer (if any) unwanted side effects.

The great fear of the pharmaceutical industry, and the vast cancer treatment system that it controls, is that a non-patentable and inexpensive cure for cancer might put them out of business. Sadly, these organizations exist to turn a profit from cancer treatment, which is measured in the billions of dollars every year. They are in the business of treating cancer not curing it.

Alternative treatments for cancer have a history of curing cancer and it is this fact that big pharma wants to hide from the American public. Historically, many successful approaches have been developed for curing cancer. We give a review of many of the most popular ones here.

Report: FDA Deliberately Deceptive – Poisoning Millions of Americans

Report: FDA Deliberately Deceptive – Poisoning Millions of Americans

Pin It

US consumers are in dark about mercury in dental products—and they are kept there deliberately by the government. This is documented in a new report being released this week by Consumers for Dental Choice called “Measurably Misleading: Evidence the FDA and Dental Industry are Deliberately Deceiving American Families about Mercury Dental Fillings and Why That Now Has International Consequences.”

Mercury is a known neurotoxin, yet mercury fillings presents one of the largest consumer consumption of mercury worldwide, and dental amalgam represents the largest use of mercury in consumer products in the US. We’ve also been kept in in the dark about mercury in other consumer products because of the FDA. Thimerosal, a mercury compound often found in flu vaccines, is being ignored as a danger.

Detox Your Liver with Homemade Lemon Water

Detox Your Liver with Homemade Lemon Water

Pin It

One of the drinks I routinely make for myself and my family in the mornings is lemon water. Not to be confused with “lemonade,” a sweetened beverage, lemon water is a detoxifying health drink consisting of nothing but one whole lemon and warm water.

Much of the research on lemon water’s ability to detoxify the liver is centered around the antioxidant D-Limonene, which is more concentrated in the peel of the lemon. D-limonene has been shown to activate enzymes in the liver that lead to detoxification. It has also been shown to treat cancer.

The Healing Properties of Clove Essential Oil

The Healing Properties of Clove Essential Oil

Pin It

The ancient texts all seem to agree on the many therapeutic properties of clove – it is a stimulant and has stomachic, expectorant, sedative, carminative, antispasmodic and digestive qualities. It helps flatulence, stimulates digestion and restores appetite, so is good for convalescence. It is a general tonic for both physical and intellectual weakness; and for those suffering from frigidity.

Its principal therapeutic value, though, is antiseptic because of the high proportion of eugenol. This is used for intestinal parasites, and for prevention of virus infections. It is good for the immune system, and particularly effective in mouth and tooth infections.

Here is a review of some of scientific studies published around the world regarding the healing properties of clove essential oil.

read more


Get the news right in your inbox!